ABSTRACT
Objective: To identify
current treatment strategies for postpartum hemorrhage used by obstetricians
(OB/GYNs) and hematologists (HEMs). Study Design: We conducted a survey of
OB/GYNs (n = 220) and HEMs
(n = 30) to describe the
characteristics of current treatment strategies for postpartum hemorrhage.
Surveys were administered via a structured questionnaire on a secure internet
website from 5 - 12 October 2009. Results: The majority of OB/GYN and HEM
respondents were practicing in a community hospital environment (77%). Of the
OB/GYNs, the majority practiced at hospitals with over 2000 deliveries per year
(77%). A majority (58%) of OB/GYNs were affiliated with hospitals that lacked a
massive transfusion protocol to treat severe postpartum hemorrhage. Subsequent
to uterine massage and additional oxytocin, the majority of OB/GYNs (73%),
preferred the administration of Methergine? as the next level of intervention for
postpartum hemorrhage. There was considerable variability in response to
specific treatment strategies for several hypothetical case scenarios; however,
the large majority of OB/GYNs favored obstetrical procedures over
interventional radiology or administration of rFVIIa. A large majority (77%) of
physicians who are familiar with rRVIIa as treatment for postpartum hemorrhage
reported being very satisfied with the agent for this indication. Conclusions:
An established, systematic treatment strategy among OB/GYNs emerged only in the
case of mild postpartum hemorrhage.
Cite this paper
Triche, E. , Wehrum, M. and Paidas, M. (2014) A Survey of Current Treatment Practices for Postpartum Hemorrhage by Practicing Obstetricians and Hematologists.
Open Journal of Obstetrics and Gynecology,
4, 279-293. doi:
10.4236/ojog.2014.46044.
References
[1] Cohen, W.R. (2006) Hemorrhagic Shock in Obstetrics. Journal of Perinatal Medicine, 34, 263-271.
http://dx.doi.org/10.1515/JPM.2006.051
[2] Johns, B., Sigurbjornsdottir, K., Fogstad, H., Zupan, J., Mathai, M. and Tan-Torres Edejer, T. (2007) Estimated Global Resources Needed to Attain Universal Coverage of Maternal and Newborn Health Services. Bull World Health Organ, 85, 256-263.
http://dx.doi.org/10.2471/BLT.06.032037
[3] Mathai, M., Gulmezoglu, A.M. and Hill, S. (2007) Saving Women’s Lives: Evidence-Based Recommendations for the Prevention of Postpartum Haemorrhage. Bull World Health Organ, 85, 322-323.
[4] Health Advisory (2004) Prevention of Maternal Deaths through Improved Management of Hemorrhage.
www.health.state.ny.us/professionals/protocols_and_guidelines/maternal_hemorrhage/
[5] American Academy of Pediatrics and American College of Obstetricians and Gynecologists (2007) Guidelines for Perinatal Care. 6th Edition, American Academy of Pediatrics and the American College of Obstetricians and Gynecologists; Washington DC.
[6] Bouwmeester, F.W., Bolte, A.C. and van Geijn, H.P. (2005) Pharmacological and Surgical Therapy for Primary Postpartum Hemorrhage. Current Pharmaceutical Design, 11, 759-773.
http://dx.doi.org/10.2174/1381612053381882
[7] Haljamae, H. (1993) The Pathophysiology of Shock. Acta Anaesthesiologica Scandinavica, 98, 3-6.
http://dx.doi.org/10.1111/j.1399-6576.1991.tb05064.x
[8] Velanovich, V. (1989) Crystalloid versus Colloid Fluid Resuscitation: A Meta-Analysis of Mortality. Surgery, 105, 65-71.
[9] Schwartz, S.I., Shires, G.T. and Spencer, F.C. (1999) Hemostasis, Surgical Bleeding, and Transfusion. In: Anonymous, Ed., Schwartz’s Principles of Surgery, 7th Edition, McGraw-Hill Professional, New York, 107-108.
[10] Matot, I., Einav, S., Goodman, S., Zeldin, A., Weissman, C. and Elchalal, U. (2004) A Survey of Physicians’ Attitudes toward Blood Transfusion in Patients Undergoing Cesarean Section. American Journal of Obstetic Gynecology, 190, 462-467.
http://dx.doi.org/10.1016/j.ajog.2003.07.028
[11] Santoso, J.T., Saunders, B.A. and Grosshart, K. (2005) Massive Blood Loss and Transfusion in Obstetrics and Gynecology. Obstetrical & Gynecological Survey, 60, 827-837.
http://dx.doi.org/10.1097/01.ogx.0000189154.98227.4b
[12] Burtelow, M., Riley, E., Druzin, M., Fontaine, M., Viele, M. and Goodnough, L.T. (2007) How We Treat: Management of Life-Threatening Primary Postpartum Hemorrhage with a Standardized Massive Transfusion Protocol. Transfusion, 47, 1564-1572.
http://dx.doi.org/10.1111/j.1537-2995.2007. 01404.x
[13] Bouma, L.S., Bolte, A.C. and van Geijn, H.P. (2008) Use of Recombinant Activated Factor VII in Massive Postpartum Haemorrhage. The European Journal of Obstetrics & Gynecology and Reproductive Biology, 137, 172-177.
http://dx.doi.org/10.1016/j.ejogrb.2007.06.022
[14] Bouwmeester, F.W., Jonkhoff, A.R., Verheijen, R.H. and van Geijn, H.P. (2003) Successful Treatment of Life-Threatening Postpartum Hemorrhage with Recombinant Activated Factor VII. Obstetrics & Gynecology, 101, 1174-1176.
http://dx.doi.org/10.1016/S0029-7844(03)00350-8
[15] Brice, A., Hilbert, U., Roger-Christoph, S., Fernandez, H., Dumenil, A.S., Descorps-Declere, A., Mercier, F. and Benhamou, D. (2004) Recombinant Activated Factor VII as a Life-Saving Therapy for Severe Postpartum Haemorrhage Unresponsive to Conservative Traditional Management. Annales Fran?aises d'Anesthésie et de Réanimation, 23, 10841088.